propidium has been researched along with alvocidib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colevas, AD; Greer, J; Karp, JE; Mann, DL; Nakanishi, T; Ross, DD; Tidwell, ML; Wei, Y; Wright, JJ; Yang, W | 1 |
| Motwani, M; Rizzo, C; Schwartz, GK; She, Y; Sirotnak, F | 1 |
2 other study(ies) available for propidium and alvocidib
| Article | Year |
|---|---|
Timed sequential therapy of acute leukemia with flavopiridol: in vitro model for a phase I clinical trial.
Topics: Adult; Aged; Antineoplastic Agents; Apoptosis; Bone Marrow Cells; Cell Division; Cell Survival; Coloring Agents; Female; Flavonoids; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Piperidines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Propidium; S Phase; Time Factors; Tumor Cells, Cultured | 2003 |
Flavopiridol enhances the effect of docetaxel in vitro and in vivo in human gastric cancer cells.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; CDC2 Protein Kinase; Cell Cycle; Cell Line, Tumor; Cyclin B; Cyclin B1; Docetaxel; Drug Synergism; Enzyme Inhibitors; Flavonoids; Flow Cytometry; Humans; Immunoblotting; In Vitro Techniques; Mitosis; Neoplasm Transplantation; Piperidines; Propidium; Retinoblastoma Protein; Stomach Neoplasms; Taxoids; Time Factors | 2003 |